Savant Capital Management »

Corcept Therapeutics Incorporated shares owned by Savant Capital Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Savant Capital Management from 13F filings

Historical chart of Savant Capital Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Savant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Savant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.8M 22k 83.11
2025-06-30 $1.4M 19k 73.40
2025-03-31 $2.3M 20k 114.22
2024-12-31 $927k 18k 50.39
2024-09-30 $850k 18k 46.28
2024-06-30 $595k 18k 32.49
2024-03-31 $321k 13k 25.19

More positions owned by Savant Capital Management

American Centy Etf Tr Avantis Emgmkt (AVEM)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Vanguard Index Fds Total Stk Mkt (VTI)
Dimensional Etf Trust Intl High Profit (DIHP)
Dimensional Etf Trust Us Mktwide Value (DFUV)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Internatnal Val (DFIV)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Global Real Est (DFGR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Savant Capital Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co
Epoch Investment Partners

View all funds holding Corcept Therapeutics Incorporated